Delivery Order SPE2DB22D1202-SPE2DB24FVPJ2

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,841.20, is for the delivery of 10 milliliter bottles of Dorzolamide HCL 2% eye drops. The contract is a firm fixed-price delivery order, with a completion date of May 16, 2025. The contract is not set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,629.36, is for the delivery of Dorzolamide HCL 2% eye drops, 10 ml, to support military healthcare programs. The contract is a firm-fixed-price Delivery Order with a completion date of May 1, 2024. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a $1,046.40 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,415,169 units of Dorzolamide HCl 2% eye drops in 10 mL bottles. The order has an ultimate completion date of August 12, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to...
This federal contract award is for the delivery of 4,566,276,890 units of Dorzolamide HCL 2% eye drops, 10 ml, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 30, 2024 with a completion date of October 31, 2024. The contract is a Delivery Order with a Firm Fixed Price of $1,093.36. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of Dorzolamide HCL 2% eye drops, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,654.30 firm fixed-price delivery order contract has an ultimate completion date of October 23, 2023. The contract is not designated as a set-aside and appears to be part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award is for the delivery of Dorzolamide HCL 2% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $2,570.95. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 11, 2024. The award was made on January 10, 2024, and there was no set-aside designation used. Amerisourcebergen...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of 4565043701 DORZOLAMIDE HCL 2% EYE DROPS 10ML to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,390.32, has a period of performance through July 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Dorzolamide-Timolol eye drops. The contract has a ceiling value of $1,046.95 and a completion date of November 4, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,293.36 Delivery Order contract is for the supply of Dorzolamide-Timolol Eye Drops 10ML. The contract is a Firm Fixed Price arrangement with a period of performance through March 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of a pharmaceutical product, specifically dorzolamide-timolol eye drops (10 ml), with a ceiling value of $1,674.06 and a period of performance ending on May 15, 2024. The contract is a firm fixed-price delivery order awarded without a set-aside designation, indicating full and open competition....
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVPJ2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dorzolamide HCL 2% eye drops in 10mL vials. The contract is a Firm Fixed Price delivery order with a ceiling value of $1,872.00 and a final completion date of September 25, 2024. The award was made on September 24, 2024 and does not utilize any set-aside designation. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical supplies to support various U.S. government agencies and healthcare programs, including the military. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the distribution of critical medical commodities.

Generated 12/24/24, 9:31 AM